Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
42.5852 wk Range
42.08Overview - IONS - Ionis Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
7.34B
P/E (Trailing)
-17.81
P/E (Forward)
-38.10
PEG Ratio
0.09
Price / Sales (TTM)
8.05
Price / Book
15.96
EV / EBITDA
-12.67
Profitability
Gross Margin
98.97%
Profit Margin
-64.65%
Operating Margin
-38.17%
Return on Assets
-12.42%
Return on Equity
-105.49%
Ownership
Shares Outstanding
165.90M
Float
164.82M
Short % of Shares Outstanding
17.94%
Held by Insiders
0.60%
Held by Institutions
110.34%
Price stats
Beta
0.38
50-Day Avg
52.65
200-Day Avg
69.34
Dividends
Payout Ratio
0.00%
Analyst Consensus
24 analysts
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IONS - Ionis Pharmaceuticals, Inc.
Peers - IONS - Ionis Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- IONSNASDAQIonis Pharmaceuticals, Inc.7.04BMarket Cap-70.81%52-week change-17.82P/E (Trailing)-64.65%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - IONS - Ionis Pharmaceuticals, Inc.
About
Ionis Pharmaceuticals, Inc. is a commercial-stage biotechnology company focused on discovering and developing RNA-targeted medicines. Using its proprietary antisense technology, Ionis creates therapies designed to modulate gene expression and address serious diseases, particularly in neurology and cardiometabolic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
